about
PNA-based probe for quantitative chemiluminescent in situ hybridisation imaging of cellular parvovirus B19 replication kinetics.Parvovirus b19 DNA CpG dinucleotide methylation and epigenetic regulation of viral expression.Resistance to parvovirus B19 infection due to lack of virus receptor (erythrocyte P antigen).Development of chemiluminescent assays for the quantitative detection and imaging of 5-bromo-2'deoxyuridine-labeled DNA in parvovirus B19-infected cells.Single-cell chemiluminescence imaging of parvovirus B19 life cycle.B19 virus genome diversity: epidemiological and clinical correlations.Gestational and fetal outcomes in B19 maternal infection: a problem of diagnosis.Parvovirus B19 Replication and Expression in Differentiating Erythroid Progenitor CellsPersistent parvovirus b19 infection resulting in carpal tunnel syndrome.Keeping pace with parvovirus B19 genetic variability: a multiplex genotype-specific quantitative PCR assay.Bone marrow necrosis and fat embolism syndrome in sickle cell disease: increased susceptibility of patients with non-SS genotypes and a possible association with human parvovirus B19 infection.Peptide nucleic acid-based in situ hybridization assay for detection of parvovirus B19 nucleic acids.Comparison of HPV sign genotyping test with INNO-LiPA HPV genotyping extra assay on histologic and cytologic cervical specimens.Hydroxyurea inhibits parvovirus B19 replication in erythroid progenitor cells.A flow-FISH assay for the quantitative analysis of parvovirus B19 infected cells.Antiviral effect of cidofovir on parvovirus B19 replication.Detection of HPV16 African variants and quantitative analysis of viral DNA methylation in oropharyngeal squamous cell carcinomas.HepG2 hepatocellular carcinoma cells are a non-permissive system for B19 virus infection.Functional analysis and quantitative determination of the expression profile of human parvovirus B19.Possible involvement of miRNAs in tropism of Parvovirus B19.Parvovirus B19 genome as a single, two-state replicative and transcriptional unit.Gastrointestinal lesions in parvovirus B19 infection.Molecular testing for detection of in vitro infectivity of plasma pools contaminated with B19 virus.Enhanced inhibition of parvovirus B19 replication by cidofovir in extendedly exposed erythroid progenitor cells.Different patterns of restriction to B19 parvovirus replication in human blast cell lines.Paradoxical response to intravenous immunoglobulin in a case of Parvovirus B19-associated chronic fatigue syndrome.Parvovirus B19 at the culprit coronary stenosis predicts outcome after stenting.Parvovirus b19 infection localized in the intestinal mucosa and associated with severe inflammatory bowel disease.Detection of adeno-associated virus DNA in female genital samples by PCR-ELISA.A new primer set improves the efficiency of competitive PCR-ELISA for the detection of B19 DNA.Evidence of human bocavirus viremia in healthy blood donors.Efficient parvovirus B19 DNA purification and molecular cloning.Meningoencephalitis with persistent parvovirus B19 infection in an apparently healthy woman.Calibrated real-time PCR for evaluation of parvovirus b19 viral load.Different syndromes associated with B19 parvovirus viraemia in paediatric patients: report of four cases.Analysis of B19 virus contamination in plasma pools for manufacturing, by using a competitive polymerase chain reaction assay.Placental endothelial cells can be productively infected by Parvovirus B19.Detection of parvovirus B19 IgG: choice of antigens and serological tests.Parvovirus B19 infection in pregnancy-awareness and opportunities.Parvovirus B19 in pregnancy: possible consequences of vertical transmission.
P50
Q33285761-ABCE34E2-91D9-4AF7-B57F-B123057D3C73Q34193790-3A4B3BFD-5813-41B9-9A3B-FBBB408FA67DQ34338090-D12FF833-C981-4989-AFCC-16C708ABFCE2Q34409281-F5B8493D-692A-4C5F-AC73-2E9648FF2E6EQ35010626-50A020CD-55EC-49D3-8379-E5CF68D2013EQ35202932-A57F6B2E-3315-48D8-B6F4-049C3F12132AQ35273671-71C966D2-2D7E-4459-8288-09C8B3E61699Q35914623-A08B8557-2E03-4EC0-A14F-C079293E0B3CQ36054855-0331B41E-EF67-4C41-BF67-D27A3830C181Q37470424-4D0402E0-325E-41B4-AE3A-6701EEAB708EQ38182209-4E935E35-5263-4576-91F0-EF2E7CF92461Q38314614-F462EE59-3753-4232-8C11-3949DD27BD5BQ38402735-D6857BAB-656A-4868-9490-47A51D43075EQ38708889-9CDE3B05-B750-44CA-831B-9BF7D2A5B1ECQ38847504-18CF45BD-F8E0-451A-B7EC-14ED6AA01E0AQ38935642-CEBF1D84-FAE5-4C6F-B1CE-80678A09BE1DQ38993326-2657D0C0-6BB5-4F3C-9302-BE2724D84951Q39917074-5972880D-B074-4772-8A5D-DFB06D0FC4A9Q39932078-0F8543AF-8D16-45F0-AFDD-A21387A9B28FQ39995843-29BADD50-1482-4FC2-A9E1-55277DEB9BE9Q40326572-78495ACF-F334-4CF6-91E7-A622C45321B8Q40400840-BCB4B19A-01A6-47AE-B052-C4D5B63116D6Q40521726-F66BF140-4A9B-410C-A0D2-7D5FE6A3AA60Q40717457-09D20A74-C7CA-4599-B278-5370628134C9Q40837334-9706A5CC-AC71-44E2-B5CF-F82D4A8C0BF9Q41580298-C74F22DA-CB1B-4964-9D04-D0783C3EF8F7Q42252171-F1AD4081-2DF0-4BEF-AA2D-4750A7DC39BEQ43127800-C97B432C-F08B-4D61-9E2C-35902C4E3777Q43685079-4A9FE1A2-390C-47DD-8C73-F5C50C210743Q43827780-7DB18EC5-C617-401F-ADE7-7FEC054DAB40Q43940210-636A4040-8C10-4996-9C42-5BF30735F9F2Q44040631-D74D0031-A856-45BD-B289-4C0BD748ABB3Q44291980-5E1D0FA6-8AFC-4794-8218-0FB80C4980AEQ44449964-9F75FB17-1BB8-4715-BEF8-3AE9663016E0Q45105758-611E96DA-4595-497B-8B02-5658CF9CD36DQ45730122-B1BD619F-5D84-4A21-AC2A-D740AA60FB85Q46212680-863BE5B0-E5EA-4F32-99D7-2CC14F6D0112Q47319479-E8969905-F654-43C8-ACDD-421B456AB845Q47592577-CEE7E5A4-1FE8-4C3B-B6D0-8B3766AE6041Q47832474-6655BAD6-0F06-4B22-B53D-99689808E39F
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Giorgio Gallinella
@ast
Giorgio Gallinella
@en
Giorgio Gallinella
@es
Giorgio Gallinella
@nl
Giorgio Gallinella
@sl
type
label
Giorgio Gallinella
@ast
Giorgio Gallinella
@en
Giorgio Gallinella
@es
Giorgio Gallinella
@nl
Giorgio Gallinella
@sl
prefLabel
Giorgio Gallinella
@ast
Giorgio Gallinella
@en
Giorgio Gallinella
@es
Giorgio Gallinella
@nl
Giorgio Gallinella
@sl
P1053
H-6864-2017
P106
P21
P31
P3829
P496
0000-0003-1118-6341